Status:
COMPLETED
Motor Development and Orthoses in Spinal Muscular Atrophy (SMA)
Lead Sponsor:
Azienda USL Reggio Emilia - IRCCS
Conditions:
Spinal Muscular Atrophy
Eligibility:
All Genders
Brief Summary
Spinal Muscular Atrophy (SMA) is neurodegenerative disease of anterior horn cells of spinal cord and represents the second more frequent pathology in childhood. According to the age of onset and the ...
Detailed Description
We collect data from patients with SMA II and SMA III referred to UDGEE from jan. 1995 to dec. 2008. We estimate to achieve informations about 50-70 patients.
Eligibility Criteria
Inclusion
- Clinical and genetics diagnosis of SMA II and SMA III
Exclusion
- N/A
Key Trial Info
Start Date :
October 12 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00961103
Start Date
October 12 2009
End Date
April 4 2011
Last Update
December 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UDGEE Hospital S.Maria Nuova
Reggio Emilia, RE, Italy, 42100